June 12, 2020
Researchers from the Garvan Institute of Medical Research have uncovered a new precision approach for treating the most common type of lung cancer, in a proof-of-principal laboratory study. The researchers discovered that blocking a specific enzyme in some lung adenocarcinoma cells could improve the efficacy of a common existing therapy. […]